Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Onchocerca volvulus | 0.005 | 0.0146 | 0.5 | |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | 5'partial|ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6339 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 3 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium vivax | sphingomyelin synthase 2, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Sphingomyelin synthase-related 1 | 0.0058 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | ATP-binding cassette sub-family B member 2 | 0.005 | 0.0146 | 0.0649 |
Echinococcus multilocularis | ATP binding cassette sub family B | 0.005 | 0.0141 | 0.6339 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 0.5 |
Entamoeba histolytica | hypothetical membrane-spanning protein | 0.0058 | 0.0222 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | multidrug resistance protein 3 | 0.005 | 0.0146 | 0.0649 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0146 | 0.0649 |
Echinococcus multilocularis | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Leishmania major | phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0549 | 0.4967 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium falciparum | sphingomyelin synthase 2, putative | 0.0058 | 0.0222 | 1 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0058 | 0.0222 | 1 |
Mycobacterium tuberculosis | Probable transmembrane multidrug efflux pump | 0.005 | 0.0146 | 0.5 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Plasmodium vivax | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | sphingomyelin synthase protein 1 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Plasmodium falciparum | sphingomyelin synthase 1, putative | 0.0058 | 0.0222 | 1 |
Schistosoma mansoni | spingomyelin synthetase-related | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | sphingomyelin synthase protein 1 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | ATP binding cassette subfamily B MDR:TAP | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Chlamydia trachomatis | ABC transporter ATP binding protein/permease | 0.005 | 0.0146 | 0.5 |
Trichomonas vaginalis | ABC transporter, half transporter, putative | 0.005 | 0.0146 | 0.6577 |
Echinococcus multilocularis | ATP binding cassette subfamily B (MDR:TAP) | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | taga, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | sphingomyelin synthetase, putative | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | ABC transporter, putative | 0.005 | 0.0146 | 0.6577 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trypanosoma cruzi | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Brugia malayi | Phosphatidylcholine:ceramide cholinephosphotransferase 2 | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | multidrug resistance protein 1, 2, putative | 0.005 | 0.0146 | 0.6577 |
Toxoplasma gondii | hypothetical protein | 0.0058 | 0.0222 | 1 |
Echinococcus granulosus | multidrug resistance protein 1 | 0.005 | 0.0146 | 0.6577 |
Trypanosoma brucei | sphingomyelin/ceramide phosphorylethanolamine synthase, bifunctional | 0.0549 | 0.4967 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0058 | 0.0222 | 1 |
Trichomonas vaginalis | ATP-binding cassette transporter, putative | 0.005 | 0.0146 | 0.6577 |
Trichomonas vaginalis | lipid A export ATP-binding/permease protein msba, putative | 0.005 | 0.0146 | 0.6577 |
Entamoeba histolytica | hypothetical protein | 0.0058 | 0.0222 | 0.0077 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0222 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0146 | 0.0649 |
Trichomonas vaginalis | abcb9, putative | 0.005 | 0.0146 | 0.6577 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.